NVS : NYSE
Industry: Pharmaceuticals

COMPANY PROFILE

Company Details

Novartis AG. The Group's principal activity is the development and manufacture of pharmaceuticals and nutritional products. The Group operates through four divisions; Pharmaceuticals, Consumer Health, Sandoz & Vaccines & Diagnostics. Pharmaceuticals Division includes drugs for use in transplantations, central nervous system disorders, cardiovascular, ... More
Shares Outstanding 2.3B
Institutional Ownership 9.33%
Market Cap 120.7B
Last Stock Split None None
Dr. Daniel Vasella Corporate Officer Address: CH-4002 Basel  www.novartis.com

Investment Ratings

NVS Highlights

First Call expects 1.06 EPS for next quarter.
The current Price Target for NVS is $57.59.


COMPANY PERFORMANCE

Pricing Momentum
54.75
Last
1.62+3.05%
Today’s Change
54.66
Today’s Open
$54.96
Day High
$54.41
Day Low
1,683,923
Volume 
Quotes delayed by at least 20 minutes

Growth Rates

Earnings per Share

Revenue

Dividend


NVS  IndustryMouse over chart for more details

Loading...
Loading...